• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. SUPERA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. SUPERA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number S-60-150-120-P6
Medical Device Problem Codes Material Separation (1562); Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/22/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported the procedure was to treat a lesion in the superficial femoral artery (sfa).The 6.0x150mm supera self expanding stent system (ses) was advanced to the target lesion; however during the process of deploying the stent, it only released half way and the tip of the delivery system detached.The ses with the partially deployed stent was removed.Outside the anatomy the stent was completely deployed.The tip of the ses was found stuck in the posterior tibial artery.A suction catheter was used to remove the detached tip.Another stent was used to complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
The device was returned for analysis.The reported material separation was able to be confirmed.The reported activation failure was unable to be replicated in a testing environment due to the condition of the returned device.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint handling database identified no other incidents from this lot.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that the distal sheath of the delivery system was bent in the narrow anatomy such that the ratchet was unable to properly/fully engage the stent resulting in the reported activation deployment failure.Manipulation of the compromised device resulted in the noted bunched/torn stent sheath likely contributing to the reported difficulties.During removal of the compromised device interaction with the narrow anatomy and/or inadvertent mishandling resulted in the reported tip material separation/noted inner member/tip separation.As reported, a suction catheter was used to remove the detached tip and another stent was used to complete the procedure.Based on the reported information and results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key21805252
Report Number2024168-2025-03653
Device Sequence Number17968657
Product Code NIP
UDI-Device Identifier08717648211843
UDI-Public(01)08717648211843(17)260430(10)4052261
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2026
Device Model NumberS-60-150-120-P6
Device Catalogue NumberS-60-150-120-P6
Device Lot Number4052261
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/25/2025
Supplement Date Received by Manufacturer04/21/2025
Initial Report FDA Received Date04/09/2025
Supplement Report FDA Received Date04/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-